Morning Overview on MSN

New CRISPR leap could transform treatment for genetic diseases

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...
Bulletin of the Atomic Scientists

CRISPR therapies can treat disease but cost millions. An equity-based approach could bring them to more people

For some diseases, gene therapies offer the potential for lifelong disease amelioration and even cure. And these immensely important novel biotechnologies may be on the cusp of a boom. That is in part ...
The Scientist

From CRISPR to Prime Editing: The Evolution of the Genome Editing Revolution

Like the human immune system, bacteria learn from past infections. CRISPR sequences—short snippets of DNA from previous viruses—guide destructive enzymes towards invading bacteriophages that express ...
Forbes

CRISPR: From Discovery To Clinic—And Charting A Path Forward

In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
Insider Monkey

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on Two Natural Cap’s Substack. In this article, we will summarize the bulls’ thesis on CRSP. CRISPR Therapeutics AG (CRSP)’s share was ...